The embolotherapy market in South & Central America is expected to grow from US$ 230.83 million in 2022 to US$ 339.16 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028.
Rising Prevalence of Cancer Fuels Embolotherapy Market in South & Central America
The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. Embolization is used to stop bleeding or block blood flow to a tumor or abnormal area of tissue. It is also used to treat liver and kidney cancer and neuroendocrine tumors. Embolizing agents, including embolic microspheres (beads), are used to restrict the vascular supply of tumors, and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. The vascular embolization device (previously the arterial embolization device) is intended to control hemorrhaging due to aneurysms, certain types of tumors, and arteriovenous malformations. The pipeline embolization device is used for the treatment of large and giant wide-neck intracranial aneurysms in the internal carotid artery. It helps prevent aneurysms and tumors from growing and causing harm to essential organs. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.
Market Overview
The embolotherapy market in South & Central America is segmented into Brazil, Argentina, and the rest of SAM. In 2021, Brazil held the largest market share. Also, the market in the country is projected to grow at the highest rate during the forecast period. The embolotherapy market in the region is expected to grow in the coming years owing to the rising prevalence of cancer and improving healthcare facilities in the countries. Brazil is the largest revenue-generating country for the embolotherapy market in South & Central America. Moreover, it is one of the fastest-growing economies across the world. Cancer is one of the primary epidemic diseases, and the number of cancer cases has doubled in the past three decades..
South & Central America Embolotherapy Market Segmentation
The South & Central America embolotherapy market is segmented into product, disease indication, procedure, end user, and country.
Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 230.83 Million |
| Market Size by 2028 | US$ 339.16 Million |
| CAGR (2022 - 2028) | 6.6% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
The South & Central America Embolotherapy Market is valued at US$ 230.83 Million in 2022, it is projected to reach US$ 339.16 Million by 2028.
As per our report South & Central America Embolotherapy Market, the market size is valued at US$ 230.83 Million in 2022, projecting it to reach US$ 339.16 Million by 2028. This translates to a CAGR of approximately 6.6% during the forecast period.
The South & Central America Embolotherapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Embolotherapy Market report:
The South & Central America Embolotherapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Embolotherapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Embolotherapy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+1 646 791 7070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Embolotherapy Market
